Makoto Ohtake to Thiosemicarbazones
This is a "connection" page, showing publications Makoto Ohtake has written about Thiosemicarbazones.
Connection Strength
0.593
-
Redox reaction and clinical outcome of primary diffuse large B-cell lymphoma of the central nervous system: Prognostic role of metabolic and textural parameters of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/computed tomography in a small patient cohort. Nucl Med Commun. 2020 Jun; 41(6):567-574.
Score: 0.189
-
Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma. Ann Nucl Med. 2018 May; 32(4):264-271.
Score: 0.162
-
Tumor hypoxia and microscopic diffusion capacity in brain tumors: a comparison of (62)Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET/CT and diffusion-weighted MR imaging. Eur J Nucl Med Mol Imaging. 2014 Jul; 41(7):1419-27.
Score: 0.124
-
(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET. AJNR Am J Neuroradiol. 2014 Feb; 35(2):278-84.
Score: 0.118